{"id":195484,"date":"2022-11-27T11:15:17","date_gmt":"2022-11-27T11:15:17","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=195484"},"modified":"2022-11-27T11:15:17","modified_gmt":"2022-11-27T11:15:17","slug":"purple-glove-syndrome","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/","title":{"rendered":"Purple glove syndrome"},"content":{"rendered":"<p>A rare, progressive, soft tissue injury characterized by progressive edema and purple discoloration of the forearm and hand. It is caused by the extravasation of phenytoin into soft tissue. Adults over the age of 60 and those with a history of peripheral vascular disease receiving intravenous phenytoin are at increased risk for PGS, but the syndrome has also been documented in patients receiving high oral doses.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A rare, progressive, soft tissue injury characterized by progressive edema and purple discoloration of the forearm and hand. It is caused by the extravasation of phenytoin into soft tissue. Adults over the age of 60 and those with a history of peripheral vascular disease receiving intravenous phenytoin are at increased risk for PGS, but the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-195484","post","type-post","status-publish","format-standard","hentry","category-p"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Purple glove syndrome - Definition of Purple glove syndrome<\/title>\n<meta name=\"description\" content=\"A rare, progressive, soft tissue injury characterized by progressive edema and purple discoloration of the forearm and hand. It is caused by the extravasation of phenytoin into soft tissue. Adults over the age of 60 and those with a history of peripheral vascular disease receiving intravenous phenytoin are at increased risk for PGS, but the syndrome has also been documented in patients receiving high oral doses.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Purple glove syndrome - Definition of Purple glove syndrome\" \/>\n<meta property=\"og:description\" content=\"A rare, progressive, soft tissue injury characterized by progressive edema and purple discoloration of the forearm and hand. It is caused by the extravasation of phenytoin into soft tissue. Adults over the age of 60 and those with a history of peripheral vascular disease receiving intravenous phenytoin are at increased risk for PGS, but the syndrome has also been documented in patients receiving high oral doses.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-27T11:15:17+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/\",\"name\":\"Purple glove syndrome - Definition of Purple glove syndrome\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-11-27T11:15:17+00:00\",\"dateModified\":\"2022-11-27T11:15:17+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A rare, progressive, soft tissue injury characterized by progressive edema and purple discoloration of the forearm and hand. It is caused by the extravasation of phenytoin into soft tissue. Adults over the age of 60 and those with a history of peripheral vascular disease receiving intravenous phenytoin are at increased risk for PGS, but the syndrome has also been documented in patients receiving high oral doses.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Purple glove syndrome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Purple glove syndrome - Definition of Purple glove syndrome","description":"A rare, progressive, soft tissue injury characterized by progressive edema and purple discoloration of the forearm and hand. It is caused by the extravasation of phenytoin into soft tissue. Adults over the age of 60 and those with a history of peripheral vascular disease receiving intravenous phenytoin are at increased risk for PGS, but the syndrome has also been documented in patients receiving high oral doses.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/","og_locale":"en_US","og_type":"article","og_title":"Purple glove syndrome - Definition of Purple glove syndrome","og_description":"A rare, progressive, soft tissue injury characterized by progressive edema and purple discoloration of the forearm and hand. It is caused by the extravasation of phenytoin into soft tissue. Adults over the age of 60 and those with a history of peripheral vascular disease receiving intravenous phenytoin are at increased risk for PGS, but the syndrome has also been documented in patients receiving high oral doses.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/","og_site_name":"Glossary","article_published_time":"2022-11-27T11:15:17+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/","name":"Purple glove syndrome - Definition of Purple glove syndrome","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-11-27T11:15:17+00:00","dateModified":"2022-11-27T11:15:17+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A rare, progressive, soft tissue injury characterized by progressive edema and purple discoloration of the forearm and hand. It is caused by the extravasation of phenytoin into soft tissue. Adults over the age of 60 and those with a history of peripheral vascular disease receiving intravenous phenytoin are at increased risk for PGS, but the syndrome has also been documented in patients receiving high oral doses.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/purple-glove-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Purple glove syndrome"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/195484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=195484"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/195484\/revisions"}],"predecessor-version":[{"id":195485,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/195484\/revisions\/195485"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=195484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=195484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=195484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}